Compare PTCT & ENIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTCT | ENIC |
|---|---|---|
| Founded | 1998 | 2016 |
| Country | United States | Chile |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 6.2B |
| IPO Year | 2006 | 2015 |
| Metric | PTCT | ENIC |
|---|---|---|
| Price | $72.07 | $4.11 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 1 |
| Target Price | ★ $80.65 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 490.0K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 4.18% |
| EPS Growth | ★ 264.48 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $264,734,000.00 | N/A |
| Revenue This Year | N/A | $96,491.22 |
| Revenue Next Year | $17.70 | $2.63 |
| P/E Ratio | ★ N/A | $101.18 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $43.18 | $3.10 |
| 52 Week High | $87.50 | $4.74 |
| Indicator | PTCT | ENIC |
|---|---|---|
| Relative Strength Index (RSI) | 53.96 | 38.16 |
| Support Level | $68.49 | $3.83 |
| Resistance Level | $73.17 | $4.15 |
| Average True Range (ATR) | 2.40 | 0.12 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 70.34 | 1.79 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Enel Chile SA is an electricity utility company engaged, through its subsidiaries and affiliates, in the generation, transmission, and distribution of electricity across Chile. The Company operates through two main segments: the Generation Business, which includes companies that own and operate power plants supplying electricity to the grid and generates the majority of revenue; and the Distribution and Network Business, which consists of companies operating under public utility concessions to distribute electricity to end customers.